Our Neuro-Oncology Program is dedicated to providing our patients with high-quality, personalized care and offers a variety of services, including high-tech neuro-imaging and complex brain and spinal tumor surgery.
Our program participates in precision and individualized medicine to discover genetic and molecular aspects of central nervous system tumors to tailor the treatment and chemotherapy protocols for each patient. We are also dedicated to preserving all motor abilities, vision, hearing and cognitive functioning and offer experimental research clinical trials when appropriate.
The pediatric Neuro-Oncology Program is strongly supported by Johns Hopkins All Children's Cancer & Blood Disorders Institute and the Institute for Brain Protection Sciences. Specialists in both institutes work closely together to discuss patient care and clinical trial status, with neuro-oncology tumor boards held weekly and molecular tumor boards held monthly.
The Johns Hopkins All Children’s neuro-oncology faculty are board-certified in their specialties, have grant funding track records and prior experience as investigators in clinical trials and cohort studies. Stacie Stapleton, M.D., director of pediatric neuro-oncology at Johns Hopkins All Children’s Hospital, has been principal investigator on multiple investigator-initiated studies and has numerous grant funds. In addition to our comprehensive team of experts, the Neuro-Oncology Program benefits from being an affiliate of the H. Lee Moffitt Cancer Center & Research Institute.
Leah Holloway I Clinical Research Coordinatorhttps://www.hopkinsallchildrens.org/